Alcon Stock Gains From CMS Decision, New Products – MDDI Index

CMS' decision to expand Medicare coverage to Alcon's AcrySof ReStor intraocular lens enhanced investor confidence in the device and helped push the stock up 22.5% for the second quarter

More from Archive

More from Medtech Insight